Sunday, May 18, 2008: 1:30 PM-5:00 PM | |||
Medical Arts Building, Rm M-146 (Queensborough Community College) | |||
BioTherapeutics | |||
Sponsor: | Pfizer | ||
Organizers: | Susan A. Rotenberg Regina Sullivan Barbara Petrak | ||
1:30 PM | Introductory Remarks | ||
1:35 PM | 28 | Development of PCK3145, a Novel Multi-Targeted Anti-Tumor Agent for Prostate Cancer Susan F. Slovin | |
1:55 PM | 29 | New Therapeutics from Transition State Theory Vern L. Schramm | |
2:15 PM | 30 | DNA Vaccines - Design, Development and Application Rangappa Ramachandra | |
2:35 PM | Break | ||
2:55 PM | 31 | Structure-Based Design of An Organoruthenium Phosphatidyl-Inositol-3-Kinase Inhibitor Reveals a Switch Governing Lipid Kinase Potency and Selectivity Peng Xie, Douglas S. Williams, G. Ekin Atilla-Gokcumen, Leslie Milk, Min Xiao, Keiran S.M. Smalley, Meenhard Herlyn, Eric Meggers, Ronen Marmorstein | |
3:15 PM | 32 | Challenges in the Production of Bio-Therapeutics Amit Banerjee | |
3:35 PM | 33 | Visual Snapshots of Intracellular Kinase Activity at the Onset of Mitosis Zhaohua Dai, Natalya G. Dulyaninova, Sanjai Kumar, Anne R. Bresnick, David S. Lawrence | |
3:55 PM | Concluding Remarks |
Back to The 40th Middle Atlantic Regional Meeting (MARM) (May 17�21, 2008)